Abstract
Background
ACTwatch project
Outlet survey methods
Results
Antimalarial availability
Antimalarial and diagnostic market composition
Antimalarial availability by class of drug
Antimalarial market share
Diagnostic blood testing availability
Frequency of diagnostic blood testing and antimalarial distribution/provision
Diagnostic market share
Provider knowledge
Provider reported supervision, support and case load reporting
Progress against the MEAF
Conclusions